Patient Guide: A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 11 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06083922
Status: 🟢 Enrolling Now
Condition: Multiple Myeloma, Monoclonal Gammopathy of Renal Significance
Phase: PHASE2

Where You Can Participate

This study is available at 11 locations across the country.

Top locations include:
  • • Boston, Massachusetts
  • • Basking Ridge, New Jersey
  • • Middletown, New Jersey
  • • And 8 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS) - Join Clinical Trial NCTNCT06083922

How to Join This Clinical Trial - NCTNCT06083922

Learn how to participate in this PHASE2 trial studying an investigational therapy for Multiple Myeloma, Monoclonal Gammopathy of Renal Significance. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Multiple Myeloma, Monoclonal Gammopathy of Renal Significance. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Multiple Myeloma, Monoclonal Gammopathy of Renal Significance
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06083922 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 11 locations. Find a study site near you:

Clinical Research Site

Boston, Massachusetts 02111 - United States

Status: RECRUITING

Clinical Research Site

Basking Ridge, New Jersey 07920 - United States

Status: RECRUITING

Clinical Research Site

Middletown, New Jersey 07748 - United States

Status: RECRUITING

Clinical Research Site

Montvale, New Jersey 07645 - United States

Status: RECRUITING

Clinical Research Site

Commack, New York 11725 - United States

Status: RECRUITING

Clinical Research Site

Harrison, New York 10604 - United States

Status: RECRUITING

Clinical Research Site

New York, New York 10021 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

New York, New York 10029 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

New York, New York 10065 - United States

Status: RECRUITING

Clinical Research Site

Uniondale, New York 11553 - United States

Status: RECRUITING

And 1 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Multiple Myeloma, Monoclonal Gammopathy of Renal Significance:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships